Preclinical to first-in-human
Clarify development logic, initial regulatory path, translational evidence and first clinical decision points.
Dose and expansion
Connect safety, PK/PD, activity, biomarker and agency expectations before expanding.
Registrational transition
Identify the evidence, design, operational and filing gaps before committing to the pivotal path.
Partnering or financing
Make the programme rationale, risks, dependencies and next value inflection legible to outsiders.